Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095091656> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2095091656 endingPage "15" @default.
- W2095091656 startingPage "11" @default.
- W2095091656 abstract "Over 12 years' experience with recombinant human growth hormone (rhGH) treatment has created a powerful and safe therapeutic tool. However, to fully optimize the potential of GH therapy and to provide a guide for future GH research, several key issues must be addressed. These are the identification of specific patients or conditions for whom rhGH provides proven long-term benefit; an understanding of when treatment should be started and stopped; a determination of the best dose and regimen; establishment of the most accurate parameter in measuring success of the treatment plan; and recognition of the therapy's potential adverse effects and their relation to dosing. To date, approved pediatric indications for GH therapy are GH deficiency, chronic renal insufficiency and Turner syndrome. Long-term benefits for other indications have yet to be clearly demonstrated. Although starting GH therapy at the youngest possible age yields better results, the treatment endpoint remains controversial. Data so far has shown that daily injections are superior to thrice weekly dosing. Bedtime administration provides more physiologic GH profiles than morning injections. Subcutaneous administration of GH is as efficacious as intramuscular GH and better tolerated. Published pilot studies and large ongoing pediatric trials suggest that the growth response is dose-dependent between 0.025 and 0.1 mg/kg per day. Studies in adults, however, show efficacy at lower doses. It appears that both auxologic and biochemical parameters are useful in assessing treatment efficacy, but which marker is best suited for indicating appropriate dose adjustments remains unclear. The normalization of serum GH-dependent growth factors may have a role in individualizing the GH dose in a similar way to the approach used in managing other endocrine deficiencies." @default.
- W2095091656 created "2016-06-24" @default.
- W2095091656 creator A5020824287 @default.
- W2095091656 creator A5054009976 @default.
- W2095091656 date "1997-01-01" @default.
- W2095091656 modified "2023-09-27" @default.
- W2095091656 title "Optimizing Growth Hormone Therapy in Children" @default.
- W2095091656 doi "https://doi.org/10.1159/000191323" @default.
- W2095091656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9434039" @default.
- W2095091656 hasPublicationYear "1997" @default.
- W2095091656 type Work @default.
- W2095091656 sameAs 2095091656 @default.
- W2095091656 citedByCount "17" @default.
- W2095091656 countsByYear W20950916562013 @default.
- W2095091656 countsByYear W20950916562014 @default.
- W2095091656 countsByYear W20950916562020 @default.
- W2095091656 countsByYear W20950916562021 @default.
- W2095091656 crossrefType "journal-article" @default.
- W2095091656 hasAuthorship W2095091656A5020824287 @default.
- W2095091656 hasAuthorship W2095091656A5054009976 @default.
- W2095091656 hasConcept C126322002 @default.
- W2095091656 hasConcept C177713679 @default.
- W2095091656 hasConcept C187212893 @default.
- W2095091656 hasConcept C197934379 @default.
- W2095091656 hasConcept C2777288759 @default.
- W2095091656 hasConcept C2778537899 @default.
- W2095091656 hasConcept C2779952775 @default.
- W2095091656 hasConcept C2781413609 @default.
- W2095091656 hasConcept C2984496839 @default.
- W2095091656 hasConcept C2994100043 @default.
- W2095091656 hasConcept C535046627 @default.
- W2095091656 hasConcept C60644358 @default.
- W2095091656 hasConcept C71315377 @default.
- W2095091656 hasConcept C71924100 @default.
- W2095091656 hasConcept C86803240 @default.
- W2095091656 hasConceptScore W2095091656C126322002 @default.
- W2095091656 hasConceptScore W2095091656C177713679 @default.
- W2095091656 hasConceptScore W2095091656C187212893 @default.
- W2095091656 hasConceptScore W2095091656C197934379 @default.
- W2095091656 hasConceptScore W2095091656C2777288759 @default.
- W2095091656 hasConceptScore W2095091656C2778537899 @default.
- W2095091656 hasConceptScore W2095091656C2779952775 @default.
- W2095091656 hasConceptScore W2095091656C2781413609 @default.
- W2095091656 hasConceptScore W2095091656C2984496839 @default.
- W2095091656 hasConceptScore W2095091656C2994100043 @default.
- W2095091656 hasConceptScore W2095091656C535046627 @default.
- W2095091656 hasConceptScore W2095091656C60644358 @default.
- W2095091656 hasConceptScore W2095091656C71315377 @default.
- W2095091656 hasConceptScore W2095091656C71924100 @default.
- W2095091656 hasConceptScore W2095091656C86803240 @default.
- W2095091656 hasIssue "5" @default.
- W2095091656 hasLocation W20950916561 @default.
- W2095091656 hasLocation W20950916562 @default.
- W2095091656 hasOpenAccess W2095091656 @default.
- W2095091656 hasPrimaryLocation W20950916561 @default.
- W2095091656 hasRelatedWork W1510870701 @default.
- W2095091656 hasRelatedWork W1970966721 @default.
- W2095091656 hasRelatedWork W1976694390 @default.
- W2095091656 hasRelatedWork W1995537591 @default.
- W2095091656 hasRelatedWork W2065740141 @default.
- W2095091656 hasRelatedWork W2292275012 @default.
- W2095091656 hasRelatedWork W2313896682 @default.
- W2095091656 hasRelatedWork W2318052490 @default.
- W2095091656 hasRelatedWork W2898650819 @default.
- W2095091656 hasRelatedWork W3030390920 @default.
- W2095091656 hasVolume "48" @default.
- W2095091656 isParatext "false" @default.
- W2095091656 isRetracted "false" @default.
- W2095091656 magId "2095091656" @default.
- W2095091656 workType "article" @default.